CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-03 | Haley Patrick J. EVP, Commercial | Grant or award | +59,411 | 303,154 | ||
| 2021-02-03 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −11,267 | $22.56 | $254K | 291,887 |
| 2021-02-03 | Senner Christopher J. EVP and CFO | Grant or award | +9,745 | 255,341 | ||
| 2021-02-03 | Senner Christopher J. EVP and CFO | Grant or award | +59,411 | 314,752 | ||
| 2021-02-03 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −18,206 | $22.56 | $411K | 296,546 |
| 2021-02-01 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +65,000 | $1.70 | $111K | 348,124 |
| 2021-02-01 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −65,000 | $22.08 | $1.4M | 283,124 |
| 2021-02-01 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion · Option (right to buy) | −65,000 | 125,000 | ||
| 2021-01-12 | Senner Christopher J. EVP and CFO | Exercise or conversion | +30,000 | $3.66 | $110K | 275,596 |
| 2021-01-12 | Senner Christopher J. EVP and CFO | Sale | −30,000 | $25.00 | $750K | 245,596 |
| 2021-01-12 | Senner Christopher J. EVP and CFO | Exercise or conversion · Option (right to buy) | −30,000 | 90,000 | ||
| 2021-01-04 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +65,000 | $1.70 | $111K | 348,124 |
| 2021-01-04 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −65,000 | $20.32 | $1.3M | 283,124 |
| 2021-01-04 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion · Option (right to buy) | −65,000 | 190,000 | ||
| 2021-01-04 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion | +30,000 | $7.27 | $218K | 521,754 |
| 2021-01-04 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion | +20,000 | $1.90 | $38K | 541,754 |
| 2021-01-04 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion · Option (right to buy) | −30,000 | 0 | ||
| 2021-01-04 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion · Option (right to buy) | −20,000 | 0 | ||
| 2020-12-28 | MORRISSEY MICHAEL President and CEO | Gift | −126,565 | 992,309 | ||
| 2020-12-18 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +65,000 | $1.70 | $111K | 348,124 |
Page 37 of 42 · 836 trades